首页> 外文期刊>ACS applied materials & interfaces >Intracellular Dynamic Disentangling of Doxorubicin Release from Luminescent Nanogold Carriers by Fluorescence Lifetime Imaging Microscopy (FLIM) under Two-Photon Excitation
【24h】

Intracellular Dynamic Disentangling of Doxorubicin Release from Luminescent Nanogold Carriers by Fluorescence Lifetime Imaging Microscopy (FLIM) under Two-Photon Excitation

机译:双光子励磁下荧光寿命显微镜(Flim)从发光纳米蛋白载体中释放多柔比星释放的细胞内动态解剖

获取原文
获取原文并翻译 | 示例
           

摘要

There is still a lack of available techniques to follow noninvasively the intracellular processes as well to track or disentangle various signals from the therapeutic agents at the site of action in the target cells. We present here the assessment of the intracellular kinetics of doxorubicin (DOX) and gold nanoparticle (AuNP) carriers by mapping simultaneously fluorescence and photoluminescence signals by fluorescence lifetime imaging microscopy under two-photon excitation (TPE-FLIM). The new nano chemotherapeutic system AuNPs@-gelatin hyd DOX has been fabricated by DOX loading onto the surface of gelatin-biosynthesized AuNPs (AuNPs@gelatin) through a pH-sensitive hydrazone bond. The successful loading of DOX onto Ili the AuNPs was studied by spectroscopic methods and steady-state fluorescence, and the nanosystem pH-responsive character was validated under simulated biological conditions at different pH values (i.e., pH 4.6, 5.3, and 7.4). Considering that the fluorescence lifetime of DOX molecules at a specific point in the cell is a reliable indicator of the discrimination of the different states of the drug in the internalization path, i.e., released versus loaded, the kinetics of AuNPsp gelatin hyd DOX cellular uptake and DOX release was compared to that of free DOX, resulting in two different drug internalization pathways. Finally, cell viability tests were conducted against NIH:OVCAR-3 cell line to prove the efficiency of our chemotherapeutic nanosystem. TPE-FLIM technique could be considered promising for noninvasive, high-resolution imaging of cells with improved capabilities over current one-photon-excited FLIM.
机译:仍然缺乏可用的技术来遵循细胞内方法,也可以跟踪或解散来自靶细胞部位的治疗剂的各种信号。在这里,我们通过在双光子激发(TPE-Flim)下通过荧光寿命显微镜进行绘制同时荧光和光致发光信号,评估多柔比蛋白(DOX)和金纳米粒子(AUNP)载体的细胞内动力学。新的纳米化学治疗系统AUNPS @ -Gelatin用DOX通过PH敏感的腙键在明胶 - 生物合成的AUNPS(AUNPS @明胶)表面上制造。通过光谱方法和稳态荧光研究了对ILI的DOX上的成功加载αUNP,并且在不同pH值(即pH 4.6,5.3和7.4)下验证纳米系统pH响应性。考虑到细胞特定点的DOX分子的荧光寿命是内化路径中药物不同状态的可靠指标,即释放与加载的释放,AUNPSP明胶氢豆细胞摄取的动力学将Dox释放与自由DOX进行比较,导致两种不同的药物内化途径。最后,对NIH的细胞活力试验进行了对NIH:OVCAR-3细胞系以证明我们的化学治疗纳米系统的效率。 TPE-FLIM技术可以被认为是对具有改进功能的细胞的非侵入性,高分辨率成像的承诺,其能够通过电流的单光子激发的爆炸的能力改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号